Nature Communications (Jan 2021)

Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy

  • Mylène Tajan,
  • Marc Hennequart,
  • Eric C. Cheung,
  • Fabio Zani,
  • Andreas K. Hock,
  • Nathalie Legrave,
  • Oliver D. K. Maddocks,
  • Rachel A. Ridgway,
  • Dimitris Athineos,
  • Alejandro Suárez-Bonnet,
  • Robert L. Ludwig,
  • Laura Novellasdemunt,
  • Nikolaos Angelis,
  • Vivian S. W. Li,
  • Georgios Vlachogiannis,
  • Nicola Valeri,
  • Nello Mainolfi,
  • Vipin Suri,
  • Adam Friedman,
  • Mark Manfredi,
  • Karen Blyth,
  • Owen J. Sansom,
  • Karen H. Vousden

DOI
https://doi.org/10.1038/s41467-020-20223-y
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 16

Abstract

Read online

Dietary serine and glycine starvation has emerged as a potential therapy for cancer. Here, the authors show that inhibition of PHGDH, which mediates the first step in the serine synthesis pathway, improves the therapeutic efficacy of serine depletion diet in mouse xenograft models.